AJMC® in the Press, April 11, 2025

Managed Care Cast News Roundup: January 13, 2026

Federal grant terminations by SAMHSA threaten vital mental health and substance use services, risking lives amid rising suicide rates and addiction crises.

January 13th 2026

Frontline Zanubrutinib-Based Therapy Shows High CR Rates in Older Patients, High-Risk MCL

This week's news roundup covers updates in health policy, technology, and access to pharmaceuticals.

Listen

“For younger, high-risk patients, zanubrutinib combined with R-BAC showed encouraging efficacy and high MRD negativity rates in a small cohort, suggesting its potential to improve prognosis and showing promise as a first-line treatment option for this population,” the authors concluded. | Image credit: fotogurmespb - stock.adobe.com

2026 Health Care Predictions: AI, GLP-1s, MAHA, DEI: Sachin H. Jain, MD, MBA

Frontline zanubrutinib regimens achieved objective response rates of 100% with deep remissions in older patients and younger, high-risk patients with MCL.

January 1st 2026

Prediabetes Plus Subclinical Myocardial Injury, Stress Significantly Increases HF Risk

Sachin H. Jain, MD, MBA, discusses 2026 health care predictions, including AI adoption, GLP-1 demand, MAHA growth, DEI’s return, and policy shifts.

Listen

Cardiovascular system - appledesign - stock.adobe.com.jpg

Central Macular Thickness Reduced With Combined Phacoemulsification With Dexamethasone Implants

Adults with hypertension who have prediabetes and subclinical myocardial injury or stress face a higher risk of incident heart failure, a study suggests.

Vision issues | Image credit: Miroslav110 - stock.adobe.com

Trump Terminates Hundreds of SAMHSA Grants, Threatening Mental Health, Addiction Services Nationwide

Visual acuity and central macular thickness improved in patients with diabetic macular edema who used combined phacoemulsification and intravitreal dexamethasone implants.

Related Content

Managed Care Cast News Roundup: January 13, 2026

Federal grant terminations by SAMHSA threaten vital mental health and substance use services, risking lives amid rising suicide rates and addiction crises.

January 13th 2026

Frontline Zanubrutinib-Based Therapy Shows High CR Rates in Older Patients, High-Risk MCL

This week's news roundup covers updates in health policy, technology, and access to pharmaceuticals.

Listen

2026 Health Care Predictions: AI, GLP-1s, MAHA, DEI: Sachin H. Jain, MD, MBA

Frontline zanubrutinib regimens achieved objective response rates of 100% with deep remissions in older patients and younger, high-risk patients with MCL.

January 1st 2026

Prediabetes Plus Subclinical Myocardial Injury, Stress Significantly Increases HF Risk

Sachin H. Jain, MD, MBA, discusses 2026 health care predictions, including AI adoption, GLP-1 demand, MAHA growth, DEI’s return, and policy shifts.

Listen

Central Macular Thickness Reduced With Combined Phacoemulsification With Dexamethasone Implants

Adults with hypertension who have prediabetes and subclinical myocardial injury or stress face a higher risk of incident heart failure, a study suggests.